Polycystic ovarian syndrome (PCOS)
25th May, 2021

  

Download PDF

 

An overview of PCOS

Polycystic ovarian syndrome (PCOS) is a complex endocrine (hormonal) and metabolic disorder. It is a leading cause of fertility problems and affects up to 20% of women.

The name comes from the appearance on an ultrasound scan of ‘polycystic’ ovaries, which means that ovaries have multiple fluid-filled sacs (follicles that appear like small cysts). However, only about 40% of women with the disorder have polycystic ovaries.

The main problems women experience are irregular periods, difficulty in controlling body weight, and skin problems (acne or unwanted hair growth).

Causes include genetics, family history (hereditary), environment, insulin resistance, low-grade inflammation and stress.

Diagnosis includes 2 out of the following 3 criteria, and exclusion of conditions with similar symptoms:

  • Irregular period
  • Clinical or biochemical signs of excess androgens
  • Polycystic ovaries on ultrasound (Not required where irregular menstrual cycles and hyperandrogenism are present and not recommended for women aged under 20).

Conventional treatments for PCOS include hormonal contraception to regulate menstrual cycles, lower androgen levels and reduce acne. Insulin-sensitising medication such as metformin is prescribed to help the body use insulin more effectively to improve ovulation. Therapies to enhance fertility include clomiphene citrate, letrozole, gonadotrophin therapy and IVF.

A healthy diet and lifestyle and maintaining a healthy weight is the best approach to improving PCOS symptoms and managing long-term health.

PCOS affects women differently, with some having only mild symptoms and others being affected quite severely. Not all symptoms are present in every woman with PCOS, and symptoms may change over time.

 

Signs and symptoms

Menstrual cycle

•        < 21 days or >35 days

•        Lack of periods (amenorrhea)

•        Unpredictable heavy menstrual bleeding

Skin & hair

•        Excess hair growth on face & body (hirsutism)

•        Darkened skin patches (acanthosis nigricans)

•        Thinning hair on scalp (alopecia)

•        Acne

•        Skin tags

Fertility

•        Difficulties in achieving a pregnancy

•        Adverse pregnancy outcomes (risk of miscarriage or gestational diabetes)

Mental/emotional

•        Depression

•        Anxiety

•        Poor body image/low self-esteem

•        Eating disorders

Metabolic

•        Weight gain/obesity

•        Increased risk factors for cardiovascular disease (cholesterol, blood pressure)

•        Increased risk of type 2 diabetes, with earlier onset

•        Sleep apnoea

 

Holistic treatment aims

  • Address underlying factors such as insulin resistance, obesity and inflammation
  • Reduce and treat consequences of androgen levels
  • Correct hormonal imbalances and normalise ovulation
  • Support adrenal function and reduce impacts of stress
  • Address health complications such as cardiovascular risk factors
  • Support emotional and mental wellbeing

 

Nutritional recommendations

Myo-inositol

• 2-4 g/day improves insulin levels, decreases androgen levels, improves ovulation, and regulates menstrual cycles.

• Dietary sources of inositol include legumes, citrus fruit, high bran cereals, nuts, and beans.

Chromium

• Can improve insulin sensitivity, reduce acne and excess hair growth.

• May improve ovulation and menstrual cycle regularity.

B vitamins

• Essential role in carbohydrate and fat metabolism.

• B6, folic acid and B12 may reduce elevated levels of homocysteine often found in PCOS.

Magnesium

• Magnesium levels are lower in women with PCOS and insulin resistance.

• May improve insulin sensitivity and blood glucose levels.

• Important for regulating stress.

Zinc

• Zinc levels are lower in women with PCOS.

• May improve insulin sensitivity, blood glucose levels and cholesterol levels.

• May reduce hair loss, excess hair growth and improve acne

Vitamin D

• Deficiencies are observed in PCOS patients with insulin resistance and obesity.

Omega-3

• May reduce inflammation, cholesterol & triglycerides, testosterone and hirsutism.

• May improve insulin resistance and menstrual cycle regularity

Alpha-lipoic acid

• May reduce glucose, insulin, triglycerides, and cholesterol.

• Combine with myo-inositol to reduce androgen levels and regulate periods.

N-acetylcysteine

• May reduce inflammation, oxidative stress, insulin resistance, cholesterol, testosterone levels.

• May improve menstrual regularity.

 

Herbal recommendations

Regulate insulin

Cinnamon, berberine-containing herbs, Gymnema

Reduce androgens & improve hirsutism

Licorice, Peony, Saw Palmetto, Spearmint

Regulate hormones

Chaste Tree, Tribulus, Black cohosh

Regulate stress & support

emotional wellbeing

Passionflower, Withania, Lavender, Rhodiola, Licorice, Lemon Balm

 

Diet & lifestyle recommendations

Diet

Eat regular meals, choosing foods with a low glycaemic index (GI), low in saturated fat, and high fibre (such as whole grains, fruits and vegetables).

Exercise

30 minutes of exercise every day, or at least 150 minutes per week.

Environmental

Limit or avoid endocrine disrupting chemicals. These are often found in plastics, canned food, soaps, non-stick cookware, make-up, and other personal care products.

Stress

Meditation, yoga, and social interaction, or counselling/psychology.

 

Seek Medical Care

Treatment recommendations should be carried out concomitant to, and not replace medical treatment. Please consult your medical doctor for advice with compatibility of nutritional/herbal recommendation and any medicine you take.

This is not an all-inclusive comprehensive list of information. Consult a qualified healthcare provider before starting any therapy. Application of clinical judgement is necessary.

Loading...
References
1Abasian Z, Rostamzadeh A, Mohammadi M, Hosseini M, Rafieian-Kopaei M. A review on role of medicinal plants in polycystic ovarian syndrome: Pathophysiology, neuroendocrine signaling, therapeutic status and future prospects. Middle East Fertility Society Journal. 2018 Dec 1;23(4):255-62.
2Ibáñez L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, Dabadghao P, Darendeliler F, Elbarbary NS, Gambineri A, Rudaz CG. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Hormone research in paediatrics. 2017;88:371-95.
3Yau TT, Ng NY, Cheung LP, Ma RC. Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences. Hong Kong Med J. 2017 Dec 1;23(6):622-34.
4[Monash University. International evidence based guideline for the assessment and management of polycystic ovary syndrome [internet]. Monash University; 2018.](https://www.monash.edu/__data/assets/pdf_file/0004/1412644/PCOS_Evidence-Based-Guidelines_20181009.pdf)
5Hoeger KM, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges, and Guiding Treatment. The Journal of Clinical Endocrinology & Metabolism. 2021 Mar;106(3):e1071-83.
6De Leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia FJ. Genetic, hormonal and metabolic aspects of PCOS: an update. Reproductive Biology and Endocrinology. 2016 Dec;14(1):1-7.
7Mimouni NE, Paiva I, Barbotin AL, Timzoura FE, Plassard D, Le Gras S, Ternier G, Pigny P, Catteau-Jonard S, Simon V, Prevot V. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell metabolism. 2021 Mar 2;33(3):513-30.
8Palioura E, Diamanti-Kandarakis E. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs). Reviews in Endocrine and Metabolic Disorders. 2015 Dec 1;16(4):365-71.
9Shorakae S, Teede H, de Courten B, Lambert G, Boyle J, Moran LJ. The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. InSeminars in reproductive medicine 2015 Jul (Vol. 33, No. 04, pp. 257-269). Thieme Medical Publishers.
10Laganà AS, Garzon S, Casarin J, Franchi M, Ghezzi F. Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends in endocrinology & metabolism. 2018 Nov 1;29(11):768-80.
11Pundir J, Psaroudakis D, Savnur P, Bhide P, Sabatini L, Teede H, Coomarasamy A, Thangaratinam S. Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta‐analysis of randomised trials. BJOG: An International Journal of Obstetrics & Gynaecology. 2018 Feb;125(3):299-308.
12Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocrine Connections. 2017 Nov 1;6(8):647-58.
13Jamilian M, Bahmani F, Siavashani MA, Mazloomi M, Asemi Z, Esmaillzadeh A. The effects of chromium supplementation on endocrine profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biological trace element research. 2016 Jul;172(1):72-8.
14Ashoush S, Abou‐Gamrah A, Bayoumy H, Othman N. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: randomized controlled trial. Journal of Obstetrics and Gynaecology Research. 2016 Mar;42(3):279-85.
15Babapour M, Mohammadi H, Kazemi M, Hadi A, Rezazadegan M, Askari G. Associations between serum magnesium concentrations and polycystic ovary syndrome status: A systematic review and meta-analysis. Biological Trace Element Research. 2021 Apr;199(4):1297-305.
16Veronese N, Watutantrige-Fernando S, Luchini C, Solmi M, Sartore G, Sergi G, Manzato E, Barbagallo M, Maggi S, Stubbs B. Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. European journal of clinical nutrition. 2016 Dec;70(12):1354-9.
17Abedini M, Ghaedi E, Hadi A, Mohammadi H, Amani R. Zinc status and polycystic ovarian syndrome: A systematic review and meta-analysis. Journal of Trace Elements in Medicine and Biology. 2019 Mar 1;52:216-21.
18Foroozanfard F, Jamilian M, Jafari Z, Khassaf A, Hosseini A, Khorammian H, Asemi Z. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Experimental and Clinical Endocrinology & Diabetes. 2015 Apr;123(04):215-20.
19Khazdouz M, Djalalinia S, Zadeh SS, Hasani M, Shidfar F, Ataie-Jafari A, Asayesh H, Zarei M, Gorabi AM, Noroozi M, Qorbani M. Effects of zinc supplementation on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials. Biological trace element research. 2019 Sep 7:1-26.
20Jamilian M, Foroozanfard F, Bahmani F, Talaee R, Monavari M, Asemi Z. Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biological trace element research. 2016 Apr 1;170(2):271-8.
21Yee BE, Richards P, Sui JY, Marsch AF. Serum zinc levels and efficacy of zinc treatment in acne vulgaris: A systematic review and meta‐analysis. Dermatologic Therapy. 2020 Nov;33(6):e14252.
22Genazzani AD, Shefer K, Della Casa D, Prati A, Napolitano A, Manzo A, Despini G, Simoncini T. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. Journal of endocrinological investigation. 2018 May;41(5):583-90.
23De Cicco S, Immediata V, Romualdi D, Policola C, Tropea A, Di Florio C, Tagliaferri V, Scarinci E, Della Casa S, Lanzone A, Apa R. Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action. Gynecological endocrinology. 2017 Sep 2;33(9):698-701.
24Yang K, Zeng L, Bao T, Ge J. Effectiveness of omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reproductive Biology and Endocrinology. 2018 Dec;16(1):1-3.
25Nadjarzadeh A, Dehghani Firouzabadi R, Vaziri N, Daneshbodi H, Lotfi MH, Mozaffari-Khosravi H. The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial. Iran J Reprod Med. 2013 Aug;11(8):665-72.
26Amini M, Bahmani F, Foroozanfard F, Vahedpoor Z, Ghaderi A, Taghizadeh M, Karbassizadeh H, Asemi Z. The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Journal of Psychosomatic Obstetrics & Gynecology. 2020 Oct 27:1-9.
27Joham AE, Teede HJ, Cassar S, Stepto NK, Strauss BJ, Harrison CL, Boyle J, de Courten B. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance. Molecular nutrition & food research. 2016 Jan;60(1):110-8.
28Kumar A, Barki S, Raghav V, Chaturvedi A, Kumar KH. Correlation of Vitamin D with metabolic parameters in polycystic ovarian syndrome. Journal of family medicine and primary care. 2017 Jan;6(1):115.
29Oner G, Muderris II. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2011 Nov 1;159(1):127-31.
30Javanmanesh F, Kashanian M, Rahimi M, Sheikhansari N. A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome. Gynecological Endocrinology. 2016 Apr 2;32(4):285-9.
31Heydarpour F, Hemati N, Hadi A, Moradi S, Mohammadi E, Farzaei MH. Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: A systematic review and meta-analysis. Journal of ethnopharmacology. 2020 May 23;254:112741.
32Kort DH, Lobo RA. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. Am J Obstet Gynecol. 2014 Nov;211(5):487.e1-6.
33Sabbadin C, Bordin L, Donà G, Manso J, Avruscio G, Armanini D. Licorice: from pseudohyperaldosteronism to therapeutic uses. Frontiers in endocrinology. 2019 Jul 18;10:484.
34Takahashi K, Kitao M. Effect of TJ-68 (shakuyaku-kanzo-to) on polycystic ovarian disease. International journal of fertility and menopausal studies. 1994 Mar 1;39(2):69-76.
35Takahashi K, Yoshino K, Shirai T, Nishigaki A, Araki Y, Kitao M. Effect of a traditional herbal medicine (shakuyaku-kanzo-to) on testosterone secretion in patients with polycystic ovary syndrome detected by ultrasound. Nihon Sanka Fujinka Gakkai Zasshi. 1988 Jun 1;40(6):789-92.
36Zhang SW, Zhou J, Gober HJ, Leung WT, Wang L. Effect and mechanism of berberine against polycystic ovary syndrome. Biomedicine & Pharmacotherapy. 2021 Jun 1;138:111468.
37Grant P, Ramasamy S. An update on plant derived anti-androgens. Int J Endocrinol Metab. 2012 Spring;10(2):497-502. doi: 10.5812/ijem.3644. Epub 2012 Apr 20. PMID: 23843810; PMCID: PMC3693613.
38Arentz S, Smith CA, Abbott J, Fahey P, Cheema BS, Bensoussan A. Combined lifestyle and herbal medicine in overweight women with polycystic ovary syndrome (PCOS): A randomized controlled trial. Phytotherapy Research. 2017 Sep;31(9):1330-40.
39Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejak J, Teucher T, Schmitz H. Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittel-forschung. 1993 Jul 1;43(7):752-6.
40Shahnazi M, Khalili AF, Hamdi K, Ghahremaninasab P. The effects of combined low-dose oral contraceptives and Vitex agnus on the improvement of clinical and paraclinical parameters of polycystic ovarian syndrome: A triple-blind, randomized, controlled clinical trial. Iranian Red Crescent Medical Journal. 2016 Dec 1;18(12).
41Grant P. Spearmint herbal tea has significant anti‐androgen effects in polycystic ovarian syndrome. A randomized controlled trial. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2010 Feb;24(2):186-8.
42Li J, Wu W, Stener-Victorin E, Ng EH, Li RH, Li M, Liu H, Lai M, Meng Y, Zheng Y, Xia Y. A prospective pilot study of the effect of acupuncture on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance. Acupuncture in Medicine. 2020 Oct;38(5):310-8.
43Wu J, Chen D, Liu N. Effectiveness of acupuncture in polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Medicine. 2020 May 29;99(22):e20441.